Health Products

VITROS Immunodiagnostic Products Estradiol Reagent Pack (2016-07-15)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: Healthcare Professionals, General Public, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
1470
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
FELINDRE MEADOWS, PENCOED, BRIDGEND
A. VITROS Immunodiagnostic Products Estradiol Reagent Pack8552630

Introduction

Affected products

A. VITROS Immunodiagnostic Products Estradiol Reagent Pack

Reason

Ortho Clinical Diagnostics (Ortho) has initiated this recall due to the potential for medications that are derivatives of estrogen (e.g. fulvestrant, brand name: Faslodex) to interfere with estradiol immunoassays and cause positively biased sample results. Fulvestrant is an estrogen receptor antagonist medication that blocks estrogen from tumors. The drug is used in the treatment of patients with metastatic, postmenopausal, hormone receptor-positive breast cancer.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime